MAIA Biotechnology (MAIA) Market Capitalization (2022 - 2026)

MAIA Biotechnology (MAIA) has reported Market Capitalization for 5 consecutive years, with $87.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Market Capitalization rose 52.91% year-over-year to $87.6 million in Q2 2026; TTM through Jun 2026 was $87.6 million, a 52.91% increase from a year earlier, with the FY2025 full-year figure at $49.1 million, down 5.13% from the prior year.
• Market Capitalization was $87.6 million for Q2 2026 at MAIA Biotechnology, up from $63.3 million in the prior quarter.
• Over five years, Market Capitalization peaked at $87.6 million in Q2 2026 and troughed at $15.5 million in Q4 2023.
• A 5-year average of $49.4 million and a median of $47.2 million in 2024 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization sank 59.65% in 2023 and jumped 233.8% in 2024, its largest moves.
• Over 5 years, Market Capitalization stood at $38.5 million in 2022, then slumped by 59.65% to $15.5 million in 2023, then jumped by 233.8% to $51.8 million in 2024, then declined by 5.13% to $49.1 million in 2025, then surged by 78.24% to $87.6 million in 2026.
• The last three Market Capitalization figures came in at $87.6 million (Q2 2026), $63.3 million (Q1 2026), and $49.1 million (Q4 2025), per Business Quant data.